Insider holders · CIK 0001933414
Mineralys Therapeutics, Inc. · MLYS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Brian Taylor SlingsbyDirector | — | 7,805,718 | 7,805,718 | Sep 24, 2026 · 9:49 pm EDT | Form 4 |
| Jon CongletonChief Executive Officer | 603,621 | — | 603,621 | Jul 15, 2026 · 8:58 pm EDT | Form 4 |
| James J. Ferguson IIIChief Medical Officer | 102,400 | — | 102,400 | Aug 12, 2026 · 7:33 pm EDT | Form 4 |
| David Malcom RodmanChief Medical Officer | 51,384 | — | 51,384 | Aug 12, 2026 · 7:33 pm EDT | Form 4 |
| Eric WarrenChief Commercial Officer | 38,400 | — | 38,400 | Sep 22, 2026 · 6:48 pm EDT | Form 4 |
| Daphne KarydasDirector | 6,200 | — | 6,200 | Sep 17, 2026 · 5:41 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.